Cell Therapeutics Granted Market Access in Italy for PIXUVRI
July 08, 2013 at 06:23 AM EDT
Cell Therapeutics (NASDAQ: CTIC ) today announced that the Company has been granted market access by the Italian Medicines Agency (AIFA) for the medicinal product PIXUVRI® (pixantrone) as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (patients with aggressive B-cell
